Key Drivers
- High ROIC
- Modest net margin
- Large intangibles
AIAI Summary
Addus now reads as a cash‑generative, capital‑efficient consolidator—organic same‑store personal‑care growth plus disciplined bolt‑ons are driving scalable margin improvement—but the investment thesis is contingent on CMS/home‑health reimbursement clarity and state rate approvals, with high intangible balances creating asymmetric downside if growth or M&A synergies falter. Actionable triggers to watch: CMS rule outcomes, key state Medicaid uplifts, and management keeping net leverage below ~1x while sustaining same‑store personal‑care growth (~5–7%+).
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High ROIC
- •Modest net margin
- •Large intangibles
ADUS delivers strong cash conversion and very high ROIC with modest net margins and conservative leverage, but heavy intangibles and elevated SG&A constrain margin resilience.
Price Behavior
Key Price Behavior Insights:
- •Moving-average resistance
- •Support at $99–$100
- •Volatile February spike
ADUS is in a short-term downtrend with the last-month moving average (~$104) above the $99.28 close, showing distribution and momentum exhaustion, but with near-term support around $99–$100 that could cap immediate losses while a reclaim above ~$104 would shift the bias back to buyers.
Sharp spike to $117.63 on 2026-02-23 followed by steady retracement indicating profit-taking and elevated tail risk
Sentiment & News
Key News Insights:
- •Revenue beat
- •EPS growth
- •Rising short interest
Addus HomeCare beat Q4 and FY25 expectations with strong revenue and adjusted EPS growth, rising adjusted EBITDA, active investor engagement, but also a notable increase in short interest.
Positive operational momentum and investor attention should support the stock near term, though elevated short interest adds downside risk to sentiment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings